Stay up to date on the latest developments in breast cancer from SABCS 2021 with VJOncology!
VJOncology were delighted to attend the San Antonio Breast Cancer Symposium (SABCS) 2021 Meeting where we caught up with speakers to get their perspectives on the most exciting updates from the meeting.
See our top editorial picks below, and more at VJOncology.com
Aditya Bardia EMERALD: elacestrant vs SOC in ER+/HER2- breast cancer Dr Bardia discusses highly anticipated results from EMERALD evaluating elacestrant in ER+/HER2- breast cancer.
Meredith Regan 12-year follow-up of SOFT & TEXT trials After 12 years follow-up, adjuvant exemestane + OFS, as compared to tamoxifen + OFS, shows a sustained reduction in risk of recurrence.
Giampaolo BianchiniSingle-cell spatial analysis in TNBC from NeoTRIPaPDL1 Single-cell spatial analysis by imaging mass cytometry and immunotherapy response in patients with TNBC enrolled in NeoTRIPaPDL1.
Cynthia X. Ma ALTERNATE: neoadjuvant endocrine treatment in ER+/HER2- breast cancer Pam50 intrinsic subtype & risk of recurrence score for the predicts endocrine sensitivity and pathologic response to chemotherapy.
Breast Cancer Sessions Register for the upcoming Breast Cancer Session!
Join Heather McArthur & Kevin Kalinsky as they review latest advances in immunotherapy presented at SABCS 2021!
16-DEC 18:00 GMT / 13:00 EST / 10:00 PST
Check out our disease channels!
Check out more developments across different disease types with our dedicated disease channels, featuring expert interviews, podcasts, roundtable discussions and more
Don't miss out on our VJSessions, expert-led roundtable discussions!
GU Cancer Sessions Join Elizabeth Plimack, Rana McKay & Thomas Powles as they discuss the latest learnings in bladder and kidney cancer from ASCO 2021
Lung Cancer Sessions Melissa Johnson, Heather Wakelee & Lizza Hendriks discuss the latest developments in the field of lung cancer presented at ASCO 2021.
